Sloning BioTechnology secures additional venture capital investments - MarketLine Financial Deals

Sloning BioTechnology secures additional venture capital investments

Sloning BioTechnology secures additional venture capital investments - MarketLine Financial Deals
Sloning BioTechnology secures additional venture capital investments
Published Sep 21, 2009
2 pages — Published Sep 21, 2009
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Sloning BioTechnology GmbH, a Germany-based protein engineering company and supplier of combinatorial gene libraries and synthetic biology tools, has secured additional investments from its institutional shareholders including, HBM BioVentures, Ltd., LBBW Venture Capital GmbH, KfW Mittelstandsbank, and Deutsche Effecten- und Wechsel-Beteiligungsgesellschaft AG (DEWB AG).

  
Source:
Document ID
MA09438_090923
Country
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Sloning BioTechnology secures additional venture capital investments" Sep 21, 2009. Alacra Store. Dec 02, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Sloning-BioTechnology-secures-additional-venture-capital-investments-2052-9114>
  
APA:
MarketLine Financial Deals. (2009). Sloning BioTechnology secures additional venture capital investments Sep 21, 2009. New York, NY: Alacra Store. Retrieved Dec 02, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Sloning-BioTechnology-secures-additional-venture-capital-investments-2052-9114>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.